Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer

  • Authors:
    • Bo Su
    • Jian Su
    • Ying Zeng
    • En Ding
    • Fang Liu
    • Tuo Tan
    • Hong Xia
    • You‑Hua Wu
    • Xi Zeng
    • Hui Ling
    • Hao Jiang
    • Xiao‑Hong Ai
    • Qi Su
  • View Affiliations

  • Published online on: March 30, 2018     https://doi.org/10.3892/or.2018.6345
  • Pages: 2797-2806
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Transforming growth factor‑β1 (TGF‑β1) has been demonstrated to promote epithelial‑mesenchymal transition (EMT), invasion and proliferation in tumors via the activation of Rac1 and β‑catenin signaling pathways. The present study investigated the effects of diallyl disulfide (DADS) on TGF‑β1‑induced EMT, invasion and growth of gastric cancer cells. TGF‑β1 treatment augmented EMT and invasion, concomitantly with increased expression of TGF‑β1, Rac1 and β‑catenin in gastric cancer cells. DADS downregulated the expression levels of TGF‑β1, Rac1 and β‑catenin. DADS, TGF‑β1 receptor inhibitor as well as Rac1 inhibitor antagonized the upregulation of the TGF‑β1‑induced expression of these genes, abolishing the enhanced effects of TGF‑β1 on EMT and invasion. Blocking the TGF‑β1 receptor through inhibition resulted in the decreased expression of Rac1 and β‑catenin. Rac1 inhibitor reduced the TGF‑β1‑induced β‑catenin expression. In addition, DADS and the aforementioned inhibitors attenuated the TGF‑β1‑induced tumor growth and the expression changes of E‑cadherin, vimentin, Ki‑67 and CD34 in nude mice. These data indicated that the blockage of TGF‑β1/Rac1 signaling by DADS may be responsible for the suppression of EMT, invasion and tumor growth in gastric cancer.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 39 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Su B, Su J, Zeng Y, Ding E, Liu F, Tan T, Xia H, Wu YH, Zeng X, Ling H, Ling H, et al: Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer. Oncol Rep 39: 2797-2806, 2018
APA
Su, B., Su, J., Zeng, Y., Ding, E., Liu, F., Tan, T. ... Su, Q. (2018). Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer. Oncology Reports, 39, 2797-2806. https://doi.org/10.3892/or.2018.6345
MLA
Su, B., Su, J., Zeng, Y., Ding, E., Liu, F., Tan, T., Xia, H., Wu, Y., Zeng, X., Ling, H., Jiang, H., Ai, X., Su, Q."Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer". Oncology Reports 39.6 (2018): 2797-2806.
Chicago
Su, B., Su, J., Zeng, Y., Ding, E., Liu, F., Tan, T., Xia, H., Wu, Y., Zeng, X., Ling, H., Jiang, H., Ai, X., Su, Q."Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer". Oncology Reports 39, no. 6 (2018): 2797-2806. https://doi.org/10.3892/or.2018.6345